The natural history of CO 2
During the history of metazoan evolution in the Phanerozoic eon, atmospheric levels of CO 2 in dry air ranged from over 6000 ppmv (0.6%) around 600-400 million years ago to 284 ppmv (0.0284%) in the mid 1800s (Berner, 2003; Berner and Kothavala, 2001; Beerling & Berner, 2005; Royer et al., 2007; Vandenbroucke et al., 2010) . Current atmospheric pCO 2 levels are approximately 387 ppmv (0.0387%), representing an increase of approximately 36% since the advent of human industrial activity. While relatively low, this level of CO 2 is key in regulation of the Earth's temperature and climate (Lacis et al., 2010) . The low background level of atmospheric CO 2 can increase dramatically in the presence of respiring organisms or decomposing organic matter (Luo et al., 2009) . In fact, a number of species use the presence of environmental CO 2 gradients as a behavioral cue including prey-seeking behavior in mosquitoes and avoidance behavior in fruitflies and nematodes (Bretscher et al., 2008; Turner & Ray, 2009 ).
In respiring metazoans, the main source of CO 2 is the electron transport chain of mitochondria where the chemical reduction of molecular oxygen is responsible for the generation of CO 2 as a by-product. Thus, in contrast to molecular oxygen, the levels of CO 2 found in tissues of the body are significantly higher than those found in the external atmosphere. A number of enzymes utilise CO 2 during their activity including Carbonic Anhydrases, a family of ubiquitously expresses metalloenzymes which are responsible for catalyzing the reversible hydration of CO 2 and H 2 O to HCO 3 and H + (De Simone & Supuran, 2010) . Remaining CO 2 is primarily removed by the blood and is exhaled or diffuses through the skin. Recent advances have demonstrated that organisms contain distinct mechanisms capable of sensing changes in CO 2 and eliciting distinct acute responses or changes in gene expression through transcriptional regulation.
Acute cellular sensing of CO 2
Many species of animal including nematodes, fruit-flies, rodents and humans possess the ability to sense CO 2 in an acute manner leading to a rapid, neuronallymediated response (Chandrashekar et al., 2009; Frommer, 2010) . For example CO 2 levels can be sensed in D. melanogaster by neurons equipped with Gr63a and Gr21a olfactory receptors leading to avoidance behavior (Jones et al., 2007) . In C.
elegans, CO 2 avoidance is also mediated by specialized neurons (Bretscher et al., 2008) . Furthermore, in humans, acute carbon dioxide sensing has been identified in the synapses of taste receptor cells in a manner dependent upon carbonic anhydrase IV (Chandrashekar et al., 2009) . Furthermore, a diverse range of CO2 sensitive potassium channels have been shown to be important in CO2 sensing in maintaining homeostasis in higher species (Tang et al, 2004) . The ability of metazoan cells to sense CO 2 acutely and initiate rapid neuronal responses is analogous in nature to the acute oxygen-sensing pathways which exist in specialized tissues such as the carotid body (Weir et al., 2005; Lopez-Barneo et al., 2009) leading to neuronal signaling to control rate and depth of breathing. It is likely that in vivo, such changes in neuronal activity will lead indirectly to CO2-induced changes in gene transcription as a consequence of altered neuronal activity.
Associations between altered neuronal activity and gene expression have been expertly described previously (Kandel, 2001) . Furthermore, previous studies have reported that stress responses to hypercapnia in animals results in increased expression of stress hormones (Schaefer et al, 1968) which can also regulate gene expression (De Kloet, 2004) . Thus altered neuronal activity and/or increased stress hormone production in vivo in response to high CO2 may be an indirect link between CO2-sensing and gene expression. In this review however, we will focus on direct mechanisms by which CO2 can regulate gene expression.
Metazoan cells have evolved the capacity to respond to changes in microenvironmental oxygen through the induction of specific adaptive gene cohorts in a manner governed by the hypoxia-inducible factor (Semenza, 2007; Kaelin & Ratcliffe, 2008) . Recent advances have indicated that an analogous transcriptional response to CO 2 may also exist in metazoan cells. The evidence supporting this will be discussed below.
CO 2 and gene expression
In studies investigating the mechanisms underpinning the protective effects of "permissive hypercapnia" in pulmonary disease, gene array analysis experiments were carried out on neonatal mice exposed to atmospheric hypercapnia (Li et al., 2006) . This study identified altered levels of pulmonary genes related to cell adhesion, growth, signal transduction and innate immunity (Li et al., 2006) . Of note in these studies, genes related to innate immunity were broadly suppressed in response to elevated CO 2 . In separate studies, exposure of the model organisms C. elegans and D. melanogaster to high CO 2 also resulted in altered gene expression (Helenius et al., 2009; Sharabi et al., 2009) . C. elegans exposure to hypercapnia impacted upon motility, fertility and lifespan which was associated with altered expression of over 6% of the transcriptome in whole animals including genes encoding proteins involved in the regulation of innate immunity (Sharabi et al., 2009) . In Drosophila, exposure to hypercapnia impaired embryonic morphogenesis, egg laying, egg hatching and innate immune responses resulting in increased susceptibility to bacterial infection which was associated with suppression of the NF-B homolog Relish in adult flies (Helenius et al., 2009 ). This response was independent of the known neuronal Gr63a CO 2 sensor, changes in extracellular pH or nitric oxide. Interestingly, in both D. melanogaster and C.
elegans, the CO 2 sensing pathway was not directly dependent upon the hydroxylase enzymes known to be important in oxygen sensing mechanisms in the hypoxia-inducible factor (HIF) pathway (reviewed by Kaelin & Ratcliffe, 2008) . A further study in mouse macrophages exposed to hypercapnia also demonstrated an immunosuppressive effect of hypercapnia as determined by decreased levels of cytokine release from cells exposed to lippopolysaccharide (Wang et al., 2010) . In this study, the authors also demonstrated a suppression of NF-B signaling which was independent of acidosis and resulted in decreased phagocytic activity of the cells (Wang et al., 2010) . A separate study also demonstrated that hypercapnia results in the suppression of NF-B signaling in mouse embryonic fibroblasts and a number of other mammalian cell types (Cummins et al., 2010) .
Thus, a common feature of the transcriptional response to elevated CO2 in mice, fruitflies and nematodes is the suppression of the genes associated with innate immunity. This suppression of immunity has been linked to decreased activity of the NF-B signaling pathway. A summary of the studies linking hypercapnia to altered NF-kB signaling is provided in Table 1 . NF-B is a master regulator of the genes involved in innate immunity and inflammation. The NF-B pathway is complex and has been expertly reviewed recently (Gilmore 2006 While the effects of in vivo hypercapnia on gene expression likely occurs in part through indirect mechanisms such as altered neuronal activity or the release of stress hormones, recent evidence suggests that CO2 may also directly regulate gene expression through the NF-kB pathway (Cummins et al., 2010) . Some insight into a possible mechanism underpinning the suppression of NF-B activity by hypercapnia was recently provided by the demonstration of CO2-induced nuclear localization of the IKK subunit (Cummins et al., 2010) . In a non-canonical manner, nuclear IKK has previously been shown to repress NF-B activity (Lawrence et al., 2005) and have a nucleosomal role in the expression of NF-B target genes including the repressor protein IB (Yamamoto et al., 2003) . Consistent with the studies outlined above, Cummins and colleagues also demonstrated the immunosupressive effects of high CO 2 were not directly dependent upon the oxygen sensing hydroxylases which regulate HIF, extracellular pH or pathways which mediate acute CO 2 -sensing in nematodes and flies (Cummins et al., 2010) .
In summary, the studies outlined above provide evidence that metazoan cells possess the capability to sense changes in microenvironmental CO 2 levels and activate a transcriptional response which results in the suppression of innate immunity and inflammatory signalling. While the specific CO 2 sensor mediating this transcriptional response has yet to be identified, the sensing mechanism appears to be independent of extracellular pH, oxygen sensing enzymes associated with the HIF pathway and mechanisms that mediate acute neuronal CO 2 sensing (Figure 1) .
The experiments excluding a role for altered pH have relied mainly on the buffering of extracellular pH or the manipulation of pH in the absence of changing CO2, neither of which elicit a transcriptional response comparible to hypercapnia (Cummins et al., 2010) . However, this does not exclude possible roles for changes in intracellular pH in mediating the response to hypercapnia. 
Crosstalk between oxygen and carbon dioxide sensing
Because of the close association between oxygen consumption and CO2 production, the capacity of a cell to sense changes in CO2 is likely closely linked to its ability to sense changes in oxygen. However, the nature of this crosstalk is poorly understood and is an area in need of further investigation. As outlined above, the oxygen sensing hydroxylases responsible for conferring oxygen/hypoxia sensitivity to the HIF pathway do not appear to play a direct role on conferring CO2 sensitivity to the NF-kB pathway. However, it should be noted that these enzymes produce CO2 during their oxygen sensing enzymatic activity in the regulation of HIF and therefore may contribute to the intracellular levels of CO2 (Figure 1) . A thorough review of the contribution of CO 2 to physiologic and pathophysiologic processes has recently been published elsewhere (Curley et al., 2010) .
Hypocapnia is the condition which arises when the mean arterial pCO 2 is lower than normal. It usually occurs as a consequence of hyperventilation in conditions such as asthma and acute lung injury. While hypocapnia is associated with adverse outcomes in diabetic ketoacidosis (Glaser et al., 2001) , therapeutic hypocapnia is used in the management strategy for brain injury associated with increased intracranial pressure (Neumann et al., 2008) .
Hypercapnia arises when the mean arterial pCO 2 is elevated above normal levels and can occur as a consequence of respiratory failure (e.g. in chronic obstructive pulmonary disease) but clinically it is commonly seen as a consequence of a low tidal volume ventilation strategy for acute respiratory distress syndrome (ARDS).
Environmental hypercapnia may also occur in the natural habitats of burrowing animals (Lechner, 1976) . Mechanical ventilation strategies to elicit normal physiological blood gas levels have been associated with stretch-induced mechanical lung damage. In the Acute Respiratory Distress Syndrome Network (ARDSnet) multi-centre trial examining lower tidal volumes as compared to traditional tidal volumes there was a significant decrease in patient mortality in the lower tidal volume group (ARDSnet, 2000) . Hypercapnic acidosis (HCA), which can be a consequence of patient hypoventilation, was also identified as being associated with decreased mortality in a subset of the ARDSnet patient cohort (patients receiving 12ml/kg tidal volumes who were defined as having hypercapnic acidosis on day 1 of the study) independent of changes in mechanical ventilation (Kregenow et al., 2006) . Taken together these data are suggestive of elevated CO 2 levels being protective in the critically ill patient.
Therapeutic hypercapnia has been reported to be of benefit in ischemia/ reperfusion injury in the mesentery (Laffey et al., 2003) and recently in the liver (Li et al., 2010) . The mechanisms for this protection are not yet fully elucidated in vivo however the latter study reports attenuated IRI-mediated pro-inflammatory gene expression (TNF), enhanced anti-inflammatory cytokine production (IL-10), decreased apoptosis and decreased immunohistochemical staining for NF-B in the hypercapnia treated groups. These studies are consistent with the observations described above for CO 2 (independent of extracellular pH) having a suppressive effect on NF-B signaling (Cummins et al., 2010; Wang et al., 2010) and of hypercapnic acidosis blunting endotoxin-stimulated NF-B signaling, resulting in decreased ICAM-1 and IL-8 expression in pulmonary endothelial cells (Takeshita et al., 2003) .
The role of intracellular acidosis in the protective effects of hypercapnia remains to be fully elucidated. In vitro experiments provide evidence that CO 2 driven antiinflammatory gene expression is independent of changes in extracellular pH (Cummins et al., 2010; Wang et al., 2010) , while in vivo studies indicate the protective effects of HCA to be dependent on acidosis in experimental models of lung injury (Laffey et al., 2000) .
Hypercapnic acidosis is associated with better prognosis in inflammatory conditions such as ARDS (Amato et al., 1998; ARDSnet, 2000) , ischemia-reperfusion injury (Li et al., 2010) and models of acute lung injury (Laffey et al., 2004) . Conversely, experiments examining bacterial-induced lung injury in mice (Nichol et al., 2009) and in pathogen-challenged Drosophila (Helenius et al., 2009) This has clear implications for the potential therapeutic applications of CO 2 in the clinic where CO 2 suppresses inflammation but also the ability to fight infection.
Therapeutic applications of CO 2
Given the increasing evidence for a potent effect of CO 2 on gene expression and in directing the course of human and animal models of disease it is important to consider the opportunities for the therapeutic manipulation of CO 2 levels.
The ARDS net tidal volume study provides clear evidence for the benefit lower tidal volumes in patients with acute lung injury and ARDs (ARDSnet, 2000) . Use of lower tidal volumes in the ICU results in associated permissive HCA and evidence from models of HCA point to the importance of elevated CO 2 in contributing to the beneficial patient outcome. However, concerns over the potential deleterious effects of CO 2 with respect to immune suppression and wound healing have stunted the progression of trials for therapeutic hypercapnia (where CO 2 is actually administered via the ventilator).
With this in mind there is perhaps more potential for therapeutic strategies directed towards controlled and localized delivery of CO 2 to an acute inflammatory locus e.g. to the gut in IBD or where organ injury can be predicted and controlled e.g in IRI or transplantation. Recent studies have pointed to the beneficial effects of CO 2 pneumoperitonieum post-laparoscopy (Ikechebelu et al., 2005) and in animal models of LPS-induced sepsis (Hanly et al., 2006) . This suggests that laparoscopic surgery with CO 2 used as the insufflating gas as may be of particular benefit in surgical procedures with a high risk of developing sepsis e.g. stomach trauma.
Summary and Conclusions
Metazoans evolved to consume oxygen and generate carbon dioxide during the process of aerobic metabolism to maximize the efficiency of metabolic processes.
As a consequence, it is not surprising that animals have evolved the ability to sense and respond to alterations in the availability of these important physiologic gasses via altered gene transcription in order to maintain metabolic homeostasis.
The ability of cells to sense oxygen deprivation (hypoxia) via reduced activity of hydroxylase enzymes resulting in the induction of the hypoxia-inducible factor (HIF) have been well characterized (Semenza, 2007; Kaelin & Ratcliffe, 2008) . However, the mechanisms by which cells sense changes in CO 2 leading to altered gene transcription remain less well understood. Recent advances have identified the repression of the NF-B transcriptional pathway by CO 2 in a manner which may be of therapeutic benefit in chronic inflammatory disease. Interestingly, NF-B is also a hypoxia-responsive transcription factor (Figure 1) . Future studies will be aimed at identifying the CO 2 sensor and determining whether crosstalk between O 2 and CO 2 sensing pathways exist at the level of transcription factors such as NF-B. CO 2 has yet to be defined. However, elevated CO 2 leads to repression of the NF-B pathway and decreased levels of genes which promote innate immunity and inflammation.
